Healthcare >> CEO Interviews >> September 13, 2002
Randy Alexander, President and CEO of IntraLase Corp., brings over 30
years of senior-level management in the ophthalmic industry. As a former
Senior Vice President of Chiron Vision, Bausch & Lomb, a manufacturer
and marketer of surgical ophthalmic devices for refractive, vitreo-
retinal and cataract surgical vision correction, Mr. Alexander was
responsible for leading the team in the acquisition and development of
Magnum Diamond, a manufacturer of Radial Keratonomy devices, where they
grew revenues from $2 million to $25 million in two years. While at
Chiron/B&L, he also created a $50 million refractive product line by
identifying the new Lasik surgical procedure and revitalized the
international businesses in Latin America, Pacific Rim and Canada by
increasing revenues from $25 million to $35 million in one year. As the
former CEO and President of Pharmacia Intermedics, a manufacturer and
marketer of surgical vision correction devices, he lead the team in
achieving profitability within 12 months, reorganized all business
functions and expanded new product development and penetrated the
international markets including Japan and Germany. Prior to that, Mr.
Alexander held key management positions where he was responsible for
worldwide sales, developed and lead product development, conducted
clinical investigations, and interfaced with the FDA. He holds MS and BS
degrees in Biological Sciences from Marshall University, Huntington,
West Virginia. Profile
then an overview of things as they are now?
Mr. Alexander: IntraLase was founded in 1997 as a startup company
